Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cunningham

Showing results (841-850 of 919) with videos related to

Pageof 92
Sort By:
Pediatric Rheumatology Online Journal|June 23, 2023
A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptationsNatoshia R Cunningham, Alaina Miller, Samantha L Ely, et al.
The Journal of Urology|January 15, 2013
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular riskAjay Nehra, Graham Jackson, Martin Miner, et al.
The Journal of Biological Chemistry|January 5, 2002
Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasiaJoseph E Dinchuk, Richard J Focht, Jennifer A Kelley, et al.
Mayo Clinic Proceedings|August 7, 2012
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular diseaseAjay Nehra, Graham Jackson, Martin Miner, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 15, 2023
Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's GuideAnup S Shetty, Tyler J Fraum, David H Ballard, et al.
The Journal of Hospital Infection|February 9, 2000
Control of MRSAM Rahman, P J Sanderson, A H Bentley, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled TrialGlenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
Pageof 92

Showing results (841-850 of 919) with videos related to

Sort By:
Pageof 92
Pediatric Rheumatology Online Journal|June 23, 2023
A multi-site pilot randomized clinical trial of the Treatment and Education Approach for Childhood-onset Lupus (TEACH) program: study design and COVID-19 adaptationsNatoshia R Cunningham, Alaina Miller, Samantha L Ely, et al.
The Journal of Urology|January 15, 2013
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular riskAjay Nehra, Graham Jackson, Martin Miner, et al.
The Journal of Biological Chemistry|January 5, 2002
Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasiaJoseph E Dinchuk, Richard J Focht, Jennifer A Kelley, et al.
Mayo Clinic Proceedings|August 7, 2012
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular diseaseAjay Nehra, Graham Jackson, Martin Miner, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 15, 2023
Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's GuideAnup S Shetty, Tyler J Fraum, David H Ballard, et al.
The Journal of Hospital Infection|February 9, 2000
Control of MRSAM Rahman, P J Sanderson, A H Bentley, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
The Journal of Sexual Medicine|August 8, 2017
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)Raymond C Rosen, Frederick Wu, Hermann M Behre, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled TrialGlenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 25, 2005
Anthrax lethal factor inhibitionW L Shoop, Y Xiong, J Wiltsie, et al.
Pageof 92